Trials
Search / Trial NCT06428084

Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing PONV

Launched by UNIVERSITAS PADJADJARAN · May 20, 2024

Trial Information

Current as of February 18, 2025

Completed

Keywords

ClinConnect Summary

Postoperative nausea and vomiting (PONV) are also known as the little problem interpreted as a seemingly less significant complication but lead to increased morbidity, longer hospital stays, increased medical costs, and diminished patient satisfaction with healthcare services. These symptoms are reported more frequently than postoperative pain, making its prevention as important as postoperative pain management. In laparoscopic cholecystectomy, the occurrence of PONV can range from 40 - 70%, which is higher than the 33 - 49% observed in other types of surgeries under general anesthesia with...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing laparoscopic cholecystectomy
  • aged 18 - 65 years
  • ASA physical status 1 and 2
  • Apfel score ≥2
  • Exclusion Criteria:
  • a history of allergies
  • routine use of antipsychotic drugs, steroids, antihistamines, and antiemetics before surgery
  • cardiac rhythm disorders
  • elevated liver enzyme levels (SGOT/SGPT) ≥5 times upper limit normal
  • BMI ≥35 kg/m2
  • Dropout Criteria:
  • if they experienced hypotension, defined as systolic blood pressure below 90 mmHg or mean arterial pressure (MAP) below 60 mmHg, or a decrease in systolic blood pressure and/or MAP greater than 20% from baseline for a duration exceeding two minutes, surgical procedures extending \>3 hours, and any alterations in the planned surgical intervention.

Trial Officials

Dian Mardiani, M.D

Principal Investigator

Faculty of Medicine Universitas Padjadjaran Bandung

About Universitas Padjadjaran

Universitas Padjadjaran, a prestigious academic institution in Indonesia, is dedicated to advancing medical research and clinical trials that contribute to the improvement of healthcare outcomes. With a strong emphasis on interdisciplinary collaboration and innovation, the university harnesses its extensive resources and expertise to conduct rigorous studies aimed at addressing pressing health challenges. Through its commitment to ethical research practices and community engagement, Universitas Padjadjaran plays a pivotal role in fostering evidence-based medicine and enhancing the quality of life for diverse populations.

Locations

Bandung, West Java, Indonesia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0